Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
The aim of this study was to describe the magnetic resonance (MR) appearances of diseases of the stomach using combined T1-weighted spoiled gradient-echo, T2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences. All patients with gastric diseases who underwent combined T2-weighted single-shot echo train spin-echo and gadolinium-enhanced conventional and fat-suppressed spoiled gradient-echo imaging between October 1, 1996 and March 1, 1999, and who had histological or other imaging proof of disease, were included in this study. This patient population was comprised of 40 patients with subsequently proven gastric abnormalities, including malignant tumors (25) or benign disease (15). The MRI sequences included T1-weighted, T2-weighted, and early and late gadolinium-enhanced spoiled gradient-echo (SGE) images. Evaluation was made of the following parameters: a) the ability to detect the disease process on MRI, by comparing the original prospective MR reports with the records of the pathology department; b) the MR appearance of a variety of gastric diseases; and c) the sequences that most clearly demonstrated abnormalities by retrospective review of the MR studies. MR images demonstrated 22 of 25 malignant tumors. Evaluation of the extent of the tumor was correctly shown in 22 of 25 tumors. Small-volume tumor (one patient with gastric adenocarcinoma, and one patient with lymphoma) and coexistent infiltrative adenocarcinoma and gastritis (one patient) rendered demonstration of tumor poor on MR images in three patients. Tumors were mildly hypointense on T1-weighted images and mildly hyperintense on T2-weighted images. Tumors enhanced in a heterogeneous fashion compared with background stomach wall, but they ranged from hypointense to hyperintense on early and late post-gadolinium SGE images. Regarding benign diseases, the changes of gastritis were evident in three of four cases. Gastritis appeared as increased mucosal enhancement that ranged from moderate to intense on early and late post-gadolinium SGE images. Imaging findings of the various entities are described in greater detail in the text. MR findings in a variety of neoplastic and non-neoplastic diseases of the stomach are described. Neoplastic diseases were consistently observed in most cases; however, small tumors and tumors coexistent with inflammatory changes were poorly evaluated. The changes of gastritis were demonstrated as increased enhancement of the gastric wall. J. Magn. Reson. Imaging 10:950-960, 1999.
Marcos
H B
HB
Department of Radiology, University of North Carolina, Chapel Hill, North Carolina 27599-7510, USA.
Semelka
R C
RC
D000230:Adenocarcinoma / Q000175:diagnosis; D000328:Adult; D000368:Aged; D003287:Contrast Media / Q000008:administration & dosage; D005260:Female; D019786:Gadolinium DTPA / Q000008:administration & dosage; D005753:Gastric Mucosa / Q000473:pathology; D005756:Gastritis / Q000175:diagnosis; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007091:Image Processing, Computer-Assisted / Q000379:methods; D007275:Injections, Intravenous; D008223:Lymphoma / Q000175:diagnosis; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012189:Retrospective Studies; D013270:Stomach / Q000473:pathology; D013272:Stomach Diseases / Q000175:diagnosis* / Q000473:pathology; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000473:pathology
D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA